Co-treatment of THP-1 cells with naringenin and curcumin induces cell cycle arrest and apoptosis via numerous pathways

Molecular Medicine Reports

Volumn 12, Issue 6, 2015, Pages 8223-8228

  Shi, Dunyun ^a   Xu, Yun ^a   Du, Xin ^a   Chen, Xuhong ^a   Zhang, Xiaoli ^a   Lou, Jin ^a   Li, Ming ^a   Zhuo, Jiacai ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SHENZHEN UNIVERSITY   (China)

Author keywords

Apoptosis; Cell cycle arrest; Curcumin; Naringenin; THP 1 cells

Indexed keywords

CURCUMIN; MITOGEN ACTIVATED PROTEIN KINASE 1; NARINGENIN; PROTEIN KINASE B; PROTEIN P53; STRESS ACTIVATED PROTEIN KINASE; ANTINEOPLASTIC AGENT; FLAVANONE DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL VIABILITY; CELL VIABILITY ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MONOCYTIC LEUKEMIA; WESTERN BLOTTING; ACUTE MYELOBLASTIC LEUKEMIA; CELL CYCLE CHECKPOINT; CELL SURVIVAL; DRUG EFFECTS; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL SURVIVAL; CURCUMIN; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLAVANONES; HUMANS; LEUKEMIA, MYELOID, ACUTE; MAP KINASE KINASE 4; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84946781848     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.4480     Document Type: Article

References (26)

1. Steffen B, Müller-Tidow C, Schwäble J, Berdel WE and Serve H: The molecular pathogenesis of acute myeloid leukemia. Crit Rev Oncol Hematol 56: 195-221, 2005.
2. Deschler B and Lübbert M: Acute myeloid leukemia: Epidemiology and etiology. Cancer 107: 2099-2107, 2006.
3. Zhou H, Beevers CS and Huang S: The targets of curcumin. Curr Drug Targets 12: 332-347, 2011.
4. Aggarwal BB and Sung B: Pharmacological basis for the role of curcumin in chronic diseases: An age-old spice with modern targets. Trends Pharmacol Sci 30: 85-94, 2009.
5. Sharma RA, Steward WP and Gescher AJ: Pharmacokinetics and pharmacodynamics of curcumin. Adv Exp Med Biol 595: 453-470, 2007.
6. Gandhy SU, Kim K, Larsen L, Rosengren RJ and Safe S: Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs. BMC Cancer 12: 564, 2012.
7. Liao YF, Hung HC, Hour TC, Hsu PC, Kao MC, Tsay GJ and Liu GY: Curcumin induces apoptosis through an ornithine decarboxylase-dependent pathway in human promyelocytic leukemia HL-60 cells. Life Sci 82: 367-375, 2008.
8. Ravindran J, Prasad S and Aggarwal BB: Curcumin and cancer cells: How many ways can curry kill tumor cells selectively?. AAPS J 11: 495-510, 2009.
9. Sabarinathan D, Mahalakshmi P and Vanisree AJ: Naringenin, a flavanone inhibits the proliferation of cerebrally implanted C6 glioma cells in rats. Chem Biol Interact 189: 26-36, 2011.
10. Ekambaram G, Rajendran P, Magesh V and Sakthisekaran D: Naringenin reduces tumor size and weight lost in N-methyl-N'-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in rats. Nutr Res 28: 106-112, 2008.
11. Qin L, Jin L, Lu L, Lu X, Zhang C, Zhang F and Liang W: Naringenin reduces lung metastasis in a breast cancer resection model. Protein Cell 2: 507-516, 2011.
12. Ahamad MS, Siddiqui S, Jafri A, Ahmad S, Afzal M and Arshad M: Induction of apoptosis and antiproliferative activity of naringenin in human epidermoid carcinoma cell through ROS generation and cell cycle arrest. PLoS One 9: e110003, 2014.
13. Arul D and Subramanian P: Naringenin (citrus flavonone) induces growth inhibition, cell cycle arrest and apoptosis in human hepatocellular carcinoma cells. Pathol Oncol Res 19: 763-770, 2013.
14. Shishodia S, Amin HM, Lai R and Aggarwal BB: Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem Pharmacol 70: 700-713, 2005.
15. Li Y, Zhang S, Geng JX and Hu XY: Curcumin inhibits human non-small cell lung cancer A549 cell proliferation through regulation of Bcl-2/Bax and cytochrome C. Asian Pac J Cancer Prev 14: 4599-4602, 2013.
16. Mehta HJ, Patel V and Sadikot RT: Curcumin and lung cancer-a review. Target Oncol 9: 295-310, 2014.
17. Cao A, Li Q, Yin P, Dong Y, Shi H, Wang L, Ji G, Xie J and Wu D: Curcumin induces apoptosis in human gastric carcinoma AGS cells and colon carcinoma HT-29 cells through mitochondrial dysfunction and endoplasmic reticulum stress. Apoptosis 18: 1391-1402, 2013.
18. Bill MA, Nicholas C, Mace TA, Etter JP, Li C, Schwartz EB, Fuchs JR, Young GS, Lin L, Lin J, et al: Structurally modified curcumin analogs inhibit STAT3 phosphorylation and promote apoptosis of human renal cell carcinoma and melanoma cell lines. PLoS One 7: e40724, 2012.
19. Cai YY, Lin WP, Li AP and Xu JY: Combined effects of curcumin and triptolide on an ovarian cancer cell line. Asian Pac J Cancer Prev 14: 4267-4271, 2013.
20. Dai XZ, Yin HT, Sun LF, Hu X, Zhou C, Zhou Y, Zhang W, Huang XE and Li XC: Potential therapeutic efficacy of curcumin in liver cancer. Asian Pac J Cancer Prev 14: 3855-3859, 2013.
21. Du Q, Hu B, An HM, Shen KP, Xu L, Deng S and Wei MM: Synergistic anticancer effects of curcumin and resveratrol in Hepa1-6 hepatocellular carcinoma cells. Oncol Rep 29: 1851-1858, 2013.
22. Mo N, Li ZQ, Li J and Cao YD: Curcumin inhibits TGF-1-induced MMP-9 and invasion through ERK and Smad signaling in breast cancer MDA-MB-231 cells. Asian Pac J Cancer Prev 13: 5709-5714, 2012.
23. Yang CW, Chang CL, Lee HC, Chi CW, Pan JP and Yang WC: Curcumin induces the apoptosis of human monocytic leukemia THP-1 cells via the activation of JNK/ERK pathways. BMC Complement Altern Med 12: 22, 2012.
24. Wang H, Geng QR, Wang L and Lu Y: Curcumin potentiates antitumor activity of L-asparaginase via inhibition of the AKT signaling pathway in acute lymphoblastic leukemia. Leuk Lymphoma 53: 1376-1382, 2012.
25. Ke CS, Liu HS, Yen CH, Huang GC, Cheng HC, Huang CY and Su CL: Curcumin-induced Aurora-A suppression not only causes mitotic defect and cell cycle arrest but also alters chemosensitivity to anticancer drugs. J Nutr Biochem 25: 526-539, 2014.
26. Park JH, Jin CY, Lee BK, Kim GY, Choi YH and Jeong YK: Naringenin induces apoptosis through downregulation of Akt and caspase-3 activation in human leukemia THP-1 cells. Food Chem Toxicol 46: 3684-3690, 2008.